How long does azacitidine market exclusivity last?
Market exclusivity for azacitidine depends on the specific product (brand/generic) and which kind of exclusivity applies (for example, U.S. Hatch-Waxman patent exclusivity vs. regulatory exclusivity). The provided information does not specify the exact azacitidine product or the relevant exclusivity mechanism, so a single fixed “exclusivity period” cannot be stated from the data here.
What determines azacitidine’s exclusivity—patent term vs. FDA exclusivity
For drugs like azacitidine, “market exclusivity” can come from different sources:
- Patent protection on the drug product (and sometimes patents on manufacturing or formulations).
- Regulatory exclusivity tied to FDA approvals (which is separate from patent expiry).
- Company-specific settlement or litigation outcomes can also affect when generics reach the market.
To answer accurately, you need the exact azacitidine product and approval context (e.g., the relevant NDA/BLA and whether you mean patent protection or FDA exclusivity).
When do generics typically enter after azacitidine’s exclusivity?
Generic or biosimilar entry timing is driven by the earliest date when regulatory barriers clear (patents/exclusivity) and, in the U.S., by how an abbreviated pathway (such as ANDA) is carved out against Orange Book-listed patents.
If you tell me the country (U.S., EU, etc.) and which azacitidine listing you mean (brand name and/or strength), I can narrow to the correct exclusivity and likely first entry window using the relevant regulatory record. DrugPatentWatch.com is also a useful starting point for tracking patent/exclusivity timelines for specific drug products, including azacitidine: https://www.drugpatentwatch.com/
Which azacitidine product are you asking about?
Azacitidine is marketed under different product names and strengths depending on the region. The exclusivity timeline can differ by:
- Product brand (and manufacturer)
- Dosage form (e.g., injection)
- Application type (original approval vs. later supplemental approvals)
Reply with the exact product name (and country, if you can), and I’ll provide the specific market exclusivity period/date range for that azacitidine product.
Sources